New Mexico Educational Retirement Board Reduces Stake in Illumina, Inc. (ILMN)
New Mexico Educational Retirement Board decreased its position in Illumina, Inc. (NASDAQ:ILMN) by 8.1% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 13,600 shares of the life sciences company’s stock after selling 1,200 shares during the period. New Mexico Educational Retirement Board’s holdings in Illumina were worth $2,364,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of the company. Advocacy Wealth Management Services LLC acquired a new stake in shares of Illumina during the first quarter valued at $102,000. Gemmer Asset Management LLC boosted its stake in shares of Illumina by 5.7% in the first quarter. Gemmer Asset Management LLC now owns 686 shares of the life sciences company’s stock valued at $117,000 after buying an additional 37 shares during the period. Advisory Services Network LLC acquired a new stake in shares of Illumina during the first quarter valued at $117,000. Patten Group Inc. boosted its stake in shares of Illumina by 2.7% in the first quarter. Patten Group Inc. now owns 965 shares of the life sciences company’s stock valued at $166,000 after buying an additional 25 shares during the period. Finally, NN Investment Partners Holdings N.V. boosted its stake in shares of Illumina by 11.3% in the second quarter. NN Investment Partners Holdings N.V. now owns 985 shares of the life sciences company’s stock valued at $171,000 after buying an additional 100 shares during the period. Institutional investors own 93.81% of the company’s stock.
Shares of Illumina, Inc. (NASDAQ:ILMN) opened at 199.23 on Thursday. The company has a market capitalization of $29.09 billion, a price-to-earnings ratio of 39.97 and a beta of 0.83. The company’s 50 day moving average is $178.82 and its 200 day moving average is $173.34. Illumina, Inc. has a one year low of $119.37 and a one year high of $199.95.
Illumina (NASDAQ:ILMN) last announced its earnings results on Tuesday, August 1st. The life sciences company reported $0.82 earnings per share for the quarter, beating analysts’ consensus estimates of $0.68 by $0.14. The business had revenue of $662 million for the quarter, compared to the consensus estimate of $642.38 million. Illumina had a net margin of 30.27% and a return on equity of 19.69%. Illumina’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period last year, the firm posted $0.86 earnings per share. Equities research analysts predict that Illumina, Inc. will post $3.65 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: This piece of content was first published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another site, it was stolen and reposted in violation of US and international copyright law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/new-mexico-educational-retirement-board-reduces-stake-in-illumina-inc-ilmn/1469408.html.
Several analysts have weighed in on ILMN shares. Piper Jaffray Companies reiterated an “overweight” rating and issued a $187.00 price objective (up previously from $170.00) on shares of Illumina in a research note on Friday, April 14th. Vetr upgraded shares of Illumina from a “buy” rating to a “strong-buy” rating and set a $196.75 price objective for the company in a research note on Monday, April 17th. Zacks Investment Research cut shares of Illumina from a “buy” rating to a “hold” rating in a research note on Thursday, April 13th. Cantor Fitzgerald lifted their price objective on shares of Illumina from $155.00 to $170.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 26th. Finally, BidaskClub upgraded shares of Illumina from a “sell” rating to a “hold” rating in a research note on Saturday, June 24th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $177.01.
In related news, Director Jay T. Flatley sold 15,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $175.53, for a total value of $2,632,950.00. Following the sale, the director now directly owns 534,176 shares of the company’s stock, valued at $93,763,913.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Charles Dadswell sold 145 shares of the firm’s stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $184.75, for a total transaction of $26,788.75. Following the completion of the sale, the senior vice president now directly owns 10,791 shares in the company, valued at $1,993,637.25. The disclosure for this sale can be found here. Insiders sold 134,010 shares of company stock worth $23,946,015 over the last ninety days. 1.60% of the stock is currently owned by insiders.
Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.
Want to see what other hedge funds are holding ILMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Illumina, Inc. (NASDAQ:ILMN).
Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.